Engineering Activities. Nisso shall undertake and subsequently complete all necessary engineering activities, equipment acquisition and commissioning, training and other activities required for the Nihongi Facility to manufacture and supply the Drug Substance meeting the Specifications in accordance with the then-current Drug Master File for the Drug Substance (excluding qualification and validation activities as provided in Section 2.3). Subject to Section 12.5(c) (Engineering Costs) hereof, all costs related to such activities shall be for the sole account of Nisso. It is acknowledged by the Parties that Nisso have already commenced such activities in accordance with the Letter Agreement.
Appears in 2 contracts
Sources: Supply Agreement (Replidyne Inc), Supply Agreement (Replidyne Inc)